The Complete Guide to ADHD: Nature, Diagnosis, and Treatment

The authors summarize research to date in gene theory and appropriately conclude that common genetic variants contribute substantially to ADHD susceptibility, but none have shown a robust association thus far. The attitudes of Europeans and Americans in the area of medication treatment for ADHD (esp...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Child and Adolescent Psychiatry Vol. 60; no. 7; pp. 925 - 927
Main Author Wigal, Tim
Format Journal Article
LanguageEnglish
Published Baltimore Elsevier Inc 01.07.2021
Elsevier BV
Subjects
Amphetamines
Attention Deficit Disorders
Attention deficit hyperactivity disorder
Case Studies
Children
Clinical Diagnosis
Clinical trials
Definitions
Drug therapy
Drugs
Genetic diversity
Medical diagnosis
Methylphenidate
Older children
Pathology
Pharmacology
Preschool Children
Resistance (Psychology)
Scientific Research
Stimulants
Susceptibility
Teaching Methods
Variants
Online AccessGet full text

Cover

More Information
Summary:The authors summarize research to date in gene theory and appropriately conclude that common genetic variants contribute substantially to ADHD susceptibility, but none have shown a robust association thus far. The attitudes of Europeans and Americans in the area of medication treatment for ADHD (especially in young children) have differed widely for years, but the guidelines in Europe are changing.1 In North America, stimulants are the first-line approach for pharmacotherapy in children older than 5 years with ADHD. A response rate of 70% is observed in treatment with methylphenidate and/or amphetamine formulations,2 but stimulants also have a significant potential for misuse.
ISSN:0890-8567
1527-5418
DOI:10.1016/j.jaac.2021.05.012